Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (70277) 70277
Newsletter (16962) 16962
Publication (4062) 4062
Newspaper Article (2360) 2360
Book Review (387) 387
Book Chapter (277) 277
Magazine Article (276) 276
Transcript (143) 143
Book / eBook (65) 65
Reference (52) 52
Conference Proceeding (48) 48
Dissertation (48) 48
Web Resource (34) 34
Trade Publication Article (25) 25
Paper (6) 6
Streaming Video (5) 5
Data Set (4) 4
Journal / eJournal (4) 4
Government Document (3) 3
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (51051) 51051
non-hodgkin's lymphomas (30635) 30635
male (27724) 27724
female (26462) 26462
middle aged (21902) 21902
adult (19615) 19615
aged (17390) 17390
oncology (17221) 17221
cancer (16279) 16279
non-hodgkins-lymphoma (15663) 15663
index medicus (15057) 15057
research (13124) 13124
hematology (12044) 12044
t cells (10291) 10291
lymphoma, non-hodgkin - pathology (9856) 9856
care and treatment (9181) 9181
lymphoma (9124) 9124
chemotherapy (9040) 9040
lymphomas (8718) 8718
prognosis (8348) 8348
adolescent (7900) 7900
lymphoma, non-hodgkin - drug therapy (7210) 7210
antineoplastic combined chemotherapy protocols - therapeutic use (6729) 6729
animals (6721) 6721
reports (5991) 5991
aged, 80 and over (5980) 5980
child (5508) 5508
treatment outcome (5420) 5420
non-hodgkin's lymphoma (5353) 5353
leukemia (4830) 4830
lymphoma, non-hodgkin - diagnosis (4815) 4815
lymphoma, non-hodgkin - therapy (4804) 4804
medical research (4799) 4799
risk factors (4679) 4679
retrospective studies (4637) 4637
rituximab (4582) 4582
pathology (4348) 4348
medicine, experimental (4326) 4326
health aspects (4201) 4201
analysis (4174) 4174
lymphoma, non-hodgkin (4143) 4143
b-cell lymphoma (4000) 4000
transplantation (3954) 3954
universities and colleges (3927) 3927
diagnosis (3860) 3860
non-hodgkin lymphoma (3856) 3856
lymphoma, non-hodgkin - complications (3647) 3647
therapy (3504) 3504
drug therapy (3347) 3347
disease (3299) 3299
diagnosis, differential (3296) 3296
genetic aspects (3258) 3258
neoplasm staging (3232) 3232
combined modality therapy (3200) 3200
non-hodgkin-lymphoma (3181) 3181
child, preschool (3146) 3146
immunohistochemistry (3107) 3107
antineoplastic agents (3091) 3091
antineoplastic agents - therapeutic use (3077) 3077
neoplasms (2983) 2983
mice (2958) 2958
tumors (2957) 2957
hemic and lymphatic diseases (2898) 2898
immunology (2849) 2849
antimitotic agents (2819) 2819
lymphoma, non-hodgkin - immunology (2816) 2816
cyclophosphamide - administration & dosage (2746) 2746
follow-up studies (2720) 2720
oncology, experimental (2707) 2707
survival (2678) 2678
lymphoma, non-hodgkin - mortality (2654) 2654
expression (2651) 2651
survival rate (2625) 2625
chronic lymphocytic-leukemia (2572) 2572
follicular lymphoma (2491) 2491
survival analysis (2475) 2475
medicine, general & internal (2474) 2474
medicine & public health (2455) 2455
young adult (2424) 2424
lymphoma, non-hodgkin - genetics (2409) 2409
sarcoma (2393) 2393
disease-free survival (2390) 2390
malignant-lymphoma (2354) 2354
lymphoma, non-hodgkin - epidemiology (2353) 2353
vincristine - administration & dosage (2349) 2349
immunotherapy (2341) 2341
biopsy (2327) 2327
lymphoma, large b-cell, diffuse - pathology (2271) 2271
classification (2231) 2231
radiotherapy (2230) 2230
time factors (2191) 2191
risk (2185) 2185
apoptosis (2180) 2180
doxorubicin - administration & dosage (2165) 2165
radiology, nuclear medicine & medical imaging (2140) 2140
lymphoma, non-hodgkin - radiotherapy (2055) 2055
stem cells (2053) 2053
clinical trials (2002) 2002
non-hodgkins-lymphomas (1988) 1988
lymphoma - pathology (1977) 1977
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (31) 31
Online Resources - Online (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Robarts - Stacks (2) 2
Scarborough Hospital - General (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (80319) 80319
German (1938) 1938
French (1905) 1905
Russian (1208) 1208
Spanish (1071) 1071
Japanese (1000) 1000
Italian (963) 963
Chinese (547) 547
Polish (432) 432
Korean (118) 118
Hungarian (114) 114
Czech (112) 112
Portuguese (111) 111
Dutch (104) 104
Romanian (89) 89
Turkish (79) 79
Danish (49) 49
Bulgarian (42) 42
Croatian (36) 36
Norwegian (35) 35
Serbian (29) 29
Swedish (29) 29
Finnish (25) 25
Hebrew (22) 22
Slovak (15) 15
Persian (8) 8
Ukrainian (8) 8
Greek (7) 7
Lithuanian (7) 7
Slovenian (3) 3
Afrikaans (2) 2
Bosnian (2) 2
Arabic (1) 1
Catalan (1) 1
Galician (1) 1
Indonesian (1) 1
Manx (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Lymphoma
by Wotherspoon, A. C and Imperial Cancer Research Fund (Great Britain)
1997, Cancer surveys, ISBN 0879695196, Volume 30., vi, 356
Book
Details down arrow
2. Lymphomas
by Sweetenham, J. W
2012, Emerging cancer therapeutics, ISBN 9781617051319, Volume 3, issue 2
Stem Cell Transplantation | Antineoplastic Agents | Lymphoma | therapeutic use | therapy
Book
Details down arrow
3. Full Text ALK - anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project
by Savage, Kerry J and Harris, Nancy Lee and Vose, Julie M and Ullrich, Fred and Jaffe, Elaine S and Connors, Joseph M and Rimsza, Lisa and Pileri, Stefano A and Chhanabhai, Mukesh and Gascoyne, Randy D and Armitage, James O and Weisenburger, Dennis D and Int Peripheral T Cell Lymphoma Pro and International Peripheral T-Cell Lymphoma Project
Blood, ISSN 0006-4971, 06/2008, Volume 111, Issue 12, pp. 5496 - 5504
The International Peripheral T-Cell Lymphoma Project is a collaborative effort designed to gain better understanding of peripheral T-cell and natural killer... 
NON-HODGKINS-LYMPHOMA | MODEL | HEMATOLOGY | PROGNOSIS | EXPRESSION | DISEASE | Lymphoma, Large-Cell, Anaplastic - immunology | Recurrence | Prognosis | Follow-Up Studies | Protein-Tyrosine Kinases - metabolism | Humans | Middle Aged | Male | North America | Protein-Tyrosine Kinases - immunology | Skin Neoplasms - mortality | Adult | Female | Retrospective Studies | Skin Neoplasms - pathology | Diagnosis, Differential | Lymphoma, Large-Cell, Anaplastic - therapy | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Europe | Immunophenotyping | Treatment Outcome | International Cooperation | Receptor Protein-Tyrosine Kinases | Lymphoma, Large-Cell, Anaplastic - mortality | Asia | Lymphoma, T-Cell, Peripheral - pathology | Survival Analysis | Lymphoma, Large-Cell, Anaplastic - pathology | Lymphoma, T-Cell, Peripheral - therapy | Lymphoma, T-Cell, Peripheral - mortality | Lymphoma, T-Cell, Peripheral - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Lymphoma
by Mugnaini, Emiliano N and Ghosh, Nilanjan
Primary Care - Clinics in Office Practice, ISSN 0095-4543, 12/2016, Volume 43, Issue 4, pp. 661 - 675
Lymphomas may be broadly divided into non-Hodgkin (90%) and Hodgkin (10%) types. Most lymphomas (90%) are of B cell origin but can also be T cell or natural... 
Diffuse large B cell | T cell | Burkitt | Non-Hodgkin | Hodgkin | Follicular | Lymphoma | MALT | MANTLE-CELL LYMPHOMA | PLUS RITUXIMAB | BRENTUXIMAB VEDOTIN | OPEN-LABEL | CHOP CHEMOTHERAPY | PIVOTAL PHASE-II | MEDICINE, GENERAL & INTERNAL | BURKITTS-LYMPHOMA | REFRACTORY HODGKINS LYMPHOMA | RESPONSE-ADAPTED THERAPY | COMBINATION CHEMOTHERAPY | PRIMARY HEALTH CARE | Decision Making | Lymphoma - therapy | Humans | Quality of Life | Lymphoma - pathology | Antineoplastic Agents - therapeutic use | Disease Management | Primary Health Care | Index Medicus
Journal Article
Details down arrow
5. Full Text Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma—Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group
by Illidge, Tim, MD, PhD and Specht, Lena, MD and Yahalom, Joachim, MD and Aleman, Berthe, MD, PhD and Berthelsen, Anne Kiil, MD and Constine, Louis, MD and Dabaja, Bouthaina, MD and Dharmarajan, Kavita, MD and Ng, Andrea, MD and Ricardi, Umberto, MD and Wirth, Andrew, MD and Int Lymphoma Radiation Oncology Gr and International Lymphoma Radiation Oncology Group
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 1, pp. 49 - 58
Radiation therapy (RT) is the most effective single modality for local control of non-Hodgkin lymphoma (NHL) and is an important component of therapy for many... 
Radiology | Hematology, Oncology and Palliative Medicine | FDG-PET | B-CELL LYMPHOMA | IMPACT | ONCOLOGY | INTENSITY-MODULATED RADIOTHERAPY | DISEASE | INVOLVED-FIELD RADIOTHERAPY | OUTCOMES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | TRANSPLANTATION | Radiotherapy Dosage | Radiotherapy Planning, Computer-Assisted - methods | Humans | Organs at Risk | Tumor Burden | Lymphoma, Non-Hodgkin - radiotherapy | Lymphoma, Non-Hodgkin - pathology | Radiotherapy Planning, Computer-Assisted - standards | Lymphatic Irradiation - standards | Adult | Combined Modality Therapy - methods | Lymphatic Irradiation - methods | Lymphoma, Non-Hodgkin - drug therapy | Care and treatment | Radiotherapy | Nuclear radiation | Tumors | Cancer | LYMPHOMAS | PATIENTS | BIOMEDICAL RADIOGRAPHY | RECOMMENDATIONS | RESPIRATION | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | PLANNING
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma
by yling, M and Thieblemont, C and Gallamini, A and Arcaini, L and Campo, E and Hermine, O and Kluin-Nelemans, J. C and Ladetto, M and Le Gouill, S and Iannitto, E and Pileri, S and Roiguez, J and Schmitz, N and Wotherspoon, A and Zinzani, P and Zucca, E
Annals of Oncology, ISSN 0923-7534, 04/2013, Volume 24, Issue 4, pp. 857 - 877
To complement the existing treatment guidelines for all tumour types, ESMO organizes consensus conferences to focus on specific issues in each type of tumour.... 
T-cell lymphoma | Mantle cell lymphoma | Marginal zone lymphoma | Malignant lymphoma guidelines | malignant lymphoma guidelines | PROSPECTIVE RANDOMIZED-TRIAL | PROGRESSION-FREE SURVIVAL | BONE-MARROW-TRANSPLANTATION | NON-HODGKINS-LYMPHOMAS | marginal zone lymphoma | LOW-GRADE LYMPHOMA | PHASE-II TRIAL | ONCOLOGY | INTERNATIONAL PROGNOSTIC INDEX | HIGH-DOSE THERAPY | mantle cell lymphoma | LONG-TERM REMISSIONS | MINIMAL RESIDUAL DISEASE | Guidelines as Topic | World Health Organization | Europe | Humans | Lymphoma, Mantle-Cell - pathology | Lymphoma, B-Cell, Marginal Zone - therapy | Lymphoma, Mantle-Cell - diagnosis | Lymphoma, Mantle-Cell - therapy | Lymphoma, B-Cell, Marginal Zone - diagnosis | Lymphoma, T-Cell - therapy | Lymphoma, T-Cell - diagnosis | Lymphoma, T-Cell - pathology | Lymphoma, B-Cell, Marginal Zone - pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Lymphoma
by Bodet-Milin, C and Itti, E and Salaun, PY
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, ISSN 0928-1258, 01/2019, Volume 43, Issue 1, pp. 150 - 160
B-CELL LYMPHOMA | POSITRON-EMISSION-TOMOGRAPHY | THERAPY RESPONSE ASSESSMENT | BURDEN FOLLICULAR LYMPHOMA | PROGRESSION-FREE SURVIVAL | BONE-MARROW INVOLVEMENT | INTERIM F-18-FDG PET | NON-HODGKIN-LYMPHOMA | INTERNATIONAL HARMONIZATION PROJECT | PATHOLOGY | METABOLIC TUMOR VOLUME
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma—evaluation by using antimüllerian hormone and retrieved oocytes
by Lawrenz, Barbara, M.D and Fehm, Tanja, Ph.D and von Wolff, Michael, Ph.D and Soekler, Martin, M.D and Huebner, Stephanie, M.D and Henes, Joerg, M.D and Henes, Melanie, M.D and Ctr FertiPROTEKT Network and Centers of FertiPROTEKT Network
Fertility and Sterility, ISSN 0015-0282, 2012, Volume 98, Issue 1, pp. 141 - 144
Objective To study whether the ovarian reserve in female lymphoma patients is already reduced before the start of chemotherapy. Design Age-matched control... 
Internal Medicine | Obstetrics and Gynecology | female lymphoma patients | Reduced ovarian reserve | fertility preservation | REPRODUCTIVE BIOLOGY | SEMEN | SERUM-LEVELS | DISEASE | CANCER | SOCIETY | OBSTETRICS & GYNECOLOGY | Oocyte Retrieval - statistics & numerical data | Ovary - pathology | Hodgkin Disease - pathology | Cell Count | Down-Regulation | Humans | Lymphoma, Non-Hodgkin - surgery | Oocytes - pathology | Hodgkin Disease - surgery | Case-Control Studies | Lymphoma, Non-Hodgkin - pathology | Young Adult | Hodgkin Disease - blood | Lymphoma, Non-Hodgkin - blood | Adolescent | Premenopause - physiology | Adult | Female | Anti-Mullerian Hormone - analysis | Anti-Mullerian Hormone - blood | Women | Chemotherapy | Menopause | Lymphomas | Hormones | Health aspects | Cancer | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients
by Gambacorti Passerini, Carlo and Passerini, Carlo Gambacorti and Farina, Francesca and Farina, Francesca and Stasia, Alessandra and Stasia, Alessandra and Redaelli, Sara and Redaelli, Sara and Ceccon, Monica and Ceccon, Monica and Mologni, Luca and Mologni, Luca and Messa, Cristina and Messa, Cristina and Guerra, Luca and Guerra, Luca and Giudici, Giovanni and Giudici, Giovanni and Sala, Elena and Sala, Elena and Mussolin, Lara and Mussolin, Lara and Deeren, Dries and Deeren, Dries and King, Michael H and King, Michael H and Steurer, Michael and Steurer, Michael and Ordemann, Rainer and Ordemann, Rainer and Cohen, Amos M and Cohen, Amos M and Grube, Matthias and Grube, Matthias and Bernard, Lea and Bernard, Lea and Chiriano, Gianpaolo and Chiriano, Gianpaolo and Antolini, Laura and Antolini, Laura and Piazza, Rocco and Piazza, Rocco
Journal of the National Cancer Institute, ISSN 0027-8874, 2014, Volume 106, Issue 2, p. djt378
Anaplastic lymphoma kinase (ALK)-positive lymphomas respond to chemotherapy, but relapses, which bear a poor prognosis, occur. Crizotinib inhibits ALK in vitro... 
ALK | TRANSLOCATION | ONCOLOGY | DISEASE | ALCL | NPM | LARGE-CELL LYMPHOMA | Immunohistochemistry | Recurrence | Pyrazoles - therapeutic use | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Lymphoma, Non-Hodgkin - enzymology | Antineoplastic Agents - administration & dosage | Protein-Tyrosine Kinases - drug effects | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Molecular Targeted Therapy - methods | Lymphoma, Non-Hodgkin - drug therapy | Pyridines - therapeutic use | Pyridines - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | In Situ Hybridization, Fluorescence | Treatment Outcome | Receptor Protein-Tyrosine Kinases - drug effects | Reverse Transcriptase Polymerase Chain Reaction | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Protein-Tyrosine Kinases - analysis | Crizotinib | Care and treatment | Chemotherapy | Patient outcomes | Dosage and administration | Lymphomas | Methods | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text B-cell Lymphomas with Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms with Clinical and Pathologic Features Distinct from Burkitt Lymphoma and Diffuse Large B-cell Lymphoma
by Snuderl, Matija and Kolman, Olga K and Chen, Yi-Bin and Hsu, Jessie J and Ackerman, Adam M and Cin, Paola Dal and Ferry, Judith A and Harris, Nancy Lee and Hasserjian, Robert P and Zukerberg, Lawrence R and Abramson, Jeremy S and Hochberg, Ephraim P and Lee, Hang and Lee, Alfred I and Toomey, Christiana E and Sohani, Aliyah R
American Journal of Surgical Pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 327 - 340
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements, also known as "double-hit'' lymphomas (DHL), are rare neoplasms characterized by highly... 
BCL2 | Cytogenetics | High-grade B-cell lymphoma | MYC | Burkitt lymphoma | Diffuse large B-cell lymphoma | high-grade B-cell lymphoma | SURGERY | MALIGNANT-LYMPHOMAS | TRANSLOCATIONS | T(14/18) | C-MYC | FOLLICULAR LYMPHOMA | diffuse large B-cell lymphoma | PATHOLOGY | cytogenetics | POLYMERASE-CHAIN-REACTION | POOR-PROGNOSIS | ACUTE LYMPHOBLASTIC-LEUKEMIA | NON-HODGKINS-LYMPHOMA | OF-THE-LITERATURE | Predictive Value of Tests | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Lymphoma, B-Cell - genetics | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Genes, Immunoglobulin Heavy Chain | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Time Factors | Karyotyping | Polymerase Chain Reaction | Aged, 80 and over | Burkitt Lymphoma - genetics | Adult | Female | Retrospective Studies | Child | Burkitt Lymphoma - therapy | Lymphoma, B-Cell - mortality | World Health Organization | Burkitt Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Terminology as Topic | Immunophenotyping | In Situ Hybridization, Fluorescence | Treatment Outcome | Lymphoma, B-Cell - classification | Lymphoma, Large B-Cell, Diffuse - mortality | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Lymphoma, B-Cell - pathology | Aged | Proto-Oncogene Proteins c-myc - genetics | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Survival of AIDS‐related diffuse large B‐cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort
by Schommers, Philipp and Hentrich, Marcus and Hoffmann, Christian and Gillor, Daniel and Zoufaly, Alexander and Jensen, Björn and Bogner, Johannes R and Thoden, Jan and Wasmuth, Jan‐Christian and Wolf, Timo and Oette, Mark and Müller, Markus and Esser, Stefan and Vehreschild, Jörg J and Fätkenheuer, Gerd and Wyen, Christoph
British Journal of Haematology, ISSN 0007-1048, 03/2015, Volume 168, Issue 6, pp. 806 - 810
Summary Overall survival (OS) of patients with acquired immunodeficiency syndrome (AIDS)‐related Burkitt lymphoma (BL), diffuse large B‐cell lymphoma (DLBCL)... 
AIDS‐related lymphoma | AIDS‐related plasmablastic lymphoma | AIDS‐related Burkitt lymphoma | AIDS‐related diffuse large B‐cell‐lymphoma | lymphoma | AIDS-related lymphoma | AIDS-related plasmablastic lymphoma | AIDS-related Burkitt lymphoma | AIDS-related diffuse large B-cell-lymphoma | Lymphoma | ACQUIRED-IMMUNODEFICIENCY-SYNDROME | CYCLOPHOSPHAMIDE | RITUXIMAB | ACTIVE ANTIRETROVIRAL THERAPY | NON-HODGKIN-LYMPHOMA | OUTCOMES | HEMATOLOGY | HIV-1 | Prognosis | Prospective Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Burkitt Lymphoma - diagnosis | CD4 Lymphocyte Count | Lymphoma, AIDS-Related - immunology | Burkitt Lymphoma - mortality | Germany - epidemiology | Lymphoma, AIDS-Related - diagnosis | Lymphoma, Large B-Cell, Diffuse - mortality | Young Adult | Lymphoma, AIDS-Related - mortality | Lymphoma, Large B-Cell, Diffuse - diagnosis | Burkitt Lymphoma - immunology | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Aged | Cohort Studies | HIV (Viruses) | AIDS (Disease) | Burkitt's lymphoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Non-Hodgkin lymphomas
by Armitage, James O., 1946
2009, 2nd ed., ISBN 9780781791168, xiv, 597
Lymphoma, Non-Hodgkin
Book
Details down arrow
13. Full Text Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)⁺ and ALK⁻ anaplastic large-cell lymphoma
by Olaf Merkel and Frank Hamacher and Daniela Laimer and Eveline Sifft and Zlatko Trajanoski and Marcel Scheideler and Gerda Egger and Melanie R. Hassler and Christiane Thallinger and Ana Schmatz and Suzanne D. Turner and Richard Greil and Lukas Kenner
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 9/2010, Volume 107, Issue 37, pp. 16228 - 16233
Aberrant anaplastic lymphoma kinase (ALK) expression is a defining feature of many human cancers and was identified first in anaplastic large-cell lymphoma... 
Tumor cell line | MicroRNA | RNA | Transgenic animals | Cell lines | Specimens | Mice | Large cell lymphoma | Lymphoma | Tumors | mTOR | micro-RNA | miR-155 | miR-101 | TARGET | TRANSLOCATION | NPM-ALK | MULTIDISCIPLINARY SCIENCES | CANCER | OVEREXPRESSION | GENE | SIGNALING PATHWAY | NON-HODGKINS-LYMPHOMA | EXPRESSION | TRANSGENIC MICE | Multigene Family | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Cell Proliferation | Protein-Tyrosine Kinases - metabolism | Gene Expression Regulation, Neoplastic | Mice, Transgenic | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Lymphoma, Large-Cell, Anaplastic - enzymology | Receptor Protein-Tyrosine Kinases | Gene Expression Regulation, Enzymologic | Xenograft Model Antitumor Assays | Protein-Tyrosine Kinases - genetics | Animals | Base Sequence | Lymphoma, Large-Cell, Anaplastic - drug therapy | Cell Line, Tumor | Lymphoma, Large-Cell, Anaplastic - pathology | MicroRNAs - genetics | Lymphoma, Large-Cell, Anaplastic - genetics | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Conjunctival Lymphoma—An International Multicenter Retrospective Study
by Kirkegaard, Marina M and Rasmussen, Peter K and Coupland, Sarah E and Esmaeli, Bita and Finger, Paul T and Graue, Gerardo F and Grossniklaus, Hans E and Honavar, Santosh G and Khong, Jwu J and McKelvie, Penny A and Mulay, Kaustubh and Prause, Jan U and Ralfkiaer, Elisabeth and Sjö, Lene D and Toft, Peter B and Vemuganti, Geeta K and Thuro, Bradley A and Curtin, Jeremy and Heegaard, Steffen
JAMA Ophthalmology, ISSN 2168-6165, 04/2016, Volume 134, Issue 4, pp. 406 - 414
IMPORTANCE: To date, the clinical features of the various subtypes of conjunctival lymphoma (CL) have not been previously evaluated in a large cohort.... 
CLINICAL-PRACTICE GUIDELINES | WALDEYERS RING | MANTLE CELL LYMPHOMA | LYMPHOPROLIFERATIVE DISEASE | OCULAR ADNEXA | OPHTHALMOLOGY | NON-HODGKIN-LYMPHOMA | FOLLOW-UP | FOLLICULAR LYMPHOMA | MARGINAL ZONE LYMPHOMA | FEATURES | Immunohistochemistry | Lymphoma, Follicular - therapy | Prognosis | Humans | Middle Aged | Lymphoma, B-Cell, Marginal Zone - therapy | Male | Burkitt Lymphoma - epidemiology | Incidence | Burkitt Lymphoma - pathology | Lymphoma, Follicular - epidemiology | Lymphoma, Large B-Cell, Diffuse - therapy | Lymphoma - therapy | Neoplasm Invasiveness - pathology | Female | Lymphoma - pathology | Lymphoma, B-Cell, Marginal Zone - pathology | Retrospective Studies | Databases, Factual | Burkitt Lymphoma - therapy | Lymphoma - epidemiology | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Lymphoma, B-Cell, Marginal Zone - epidemiology | Conjunctival Neoplasms - therapy | Conjunctival Neoplasms - pathology | Disease-Free Survival | Conjunctival Neoplasms - epidemiology | Internationality | Lymphoma, Large B-Cell, Diffuse - epidemiology | Survival Analysis | Aged | Biopsy, Needle | Neoplasm Staging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights